Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 8,510.00
+160.00 (1.92%)
At close: Apr 29, 2026
Keeps Biopharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 22,044 | 18,777 | 4,106 | 23,625 | 37,197 | Upgrade
|
| Short-Term Investments | 1,879 | 3,934 | 756.56 | 30 | 3,092 | Upgrade
|
| Trading Asset Securities | 2,649 | 276.08 | 6,047 | 1,549 | 600.6 | Upgrade
|
| Cash & Short-Term Investments | 26,571 | 22,988 | 10,910 | 25,203 | 40,889 | Upgrade
|
| Cash Growth | 15.59% | 110.71% | -56.71% | -38.36% | 28.98% | Upgrade
|
| Accounts Receivable | 20,979 | 16,256 | 9,677 | 6,194 | 6,718 | Upgrade
|
| Other Receivables | 288.65 | 460.57 | 1,925 | 212.39 | 332.01 | Upgrade
|
| Receivables | 21,267 | 16,716 | 13,246 | 6,407 | 12,850 | Upgrade
|
| Inventory | 31,524 | 20,436 | 5,328 | 1,602 | 2,246 | Upgrade
|
| Prepaid Expenses | 633.76 | 828.01 | 113.06 | 53.6 | 42.96 | Upgrade
|
| Other Current Assets | 22,386 | 9,746 | 17,169 | 10,044 | 7,315 | Upgrade
|
| Total Current Assets | 102,382 | 70,714 | 46,766 | 43,310 | 63,342 | Upgrade
|
| Property, Plant & Equipment | 43,636 | 35,068 | 28,376 | 10,062 | 10,365 | Upgrade
|
| Long-Term Investments | 10,297 | 15,110 | 9,216 | 18,369 | 16,906 | Upgrade
|
| Goodwill | 29,516 | 29,250 | 23,970 | - | - | Upgrade
|
| Other Intangible Assets | 21,905 | 11,514 | 6,596 | 958.46 | 965.41 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0 | 129.69 | 361.77 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 312.11 | 1,528 | - | - | Upgrade
|
| Other Long-Term Assets | 24,573 | 5,021 | 826.23 | 6,367 | 1,462 | Upgrade
|
| Total Assets | 233,917 | 166,989 | 117,279 | 85,559 | 93,401 | Upgrade
|
| Accounts Payable | 3,915 | 5,925 | 2,765 | 630.13 | 768.35 | Upgrade
|
| Accrued Expenses | 2,432 | 1,969 | 1,956 | 744.98 | 901.09 | Upgrade
|
| Short-Term Debt | 35,066 | 41,640 | 47,904 | 28,124 | 26,755 | Upgrade
|
| Current Portion of Long-Term Debt | 9,693 | 330.72 | - | - | - | Upgrade
|
| Current Portion of Leases | 333.82 | 276.49 | 308.59 | 310.16 | 276.52 | Upgrade
|
| Current Income Taxes Payable | 697.83 | 2,991 | - | - | - | Upgrade
|
| Other Current Liabilities | 37,271 | 32,661 | 2,946 | 2,250 | 1,496 | Upgrade
|
| Total Current Liabilities | 89,407 | 85,793 | 55,880 | 32,059 | 30,197 | Upgrade
|
| Long-Term Debt | 47,347 | 13,427 | - | - | - | Upgrade
|
| Long-Term Leases | 153.67 | 62.85 | 91.93 | 386.34 | 571.69 | Upgrade
|
| Pension & Post-Retirement Benefits | 237.46 | 424.77 | 525.41 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5,232 | 2,526 | 356.28 | 248.32 | 766.68 | Upgrade
|
| Other Long-Term Liabilities | 10,037 | 1,340 | 1,846 | 597.55 | 978.75 | Upgrade
|
| Total Liabilities | 152,415 | 103,574 | 58,699 | 33,291 | 32,514 | Upgrade
|
| Common Stock | 10,039 | 9,374 | 9,374 | 9,374 | 9,268 | Upgrade
|
| Additional Paid-In Capital | 61,665 | 36,806 | 67,866 | 67,691 | 64,242 | Upgrade
|
| Retained Earnings | -2,469 | 7,270 | -23,631 | -27,455 | -15,188 | Upgrade
|
| Comprehensive Income & Other | -7,224 | -3,317 | 3,627 | 3,462 | 2,704 | Upgrade
|
| Total Common Equity | 62,011 | 50,134 | 57,236 | 53,072 | 61,026 | Upgrade
|
| Minority Interest | 19,492 | 13,282 | 1,343 | -804.49 | -139.37 | Upgrade
|
| Shareholders' Equity | 81,503 | 63,415 | 58,579 | 52,268 | 60,887 | Upgrade
|
| Total Liabilities & Equity | 233,917 | 166,989 | 117,279 | 85,559 | 93,401 | Upgrade
|
| Total Debt | 92,593 | 55,737 | 48,304 | 28,820 | 27,603 | Upgrade
|
| Net Cash (Debt) | -66,022 | -32,749 | -37,395 | -3,617 | 13,286 | Upgrade
|
| Net Cash Growth | - | - | - | - | 21.17% | Upgrade
|
| Net Cash Per Share | -3366.81 | -1735.34 | -1987.66 | -193.02 | 767.26 | Upgrade
|
| Filing Date Shares Outstanding | 20.05 | 18.75 | 18.75 | 18.75 | 18.54 | Upgrade
|
| Total Common Shares Outstanding | 20.05 | 18.75 | 18.75 | 18.75 | 18.54 | Upgrade
|
| Working Capital | 12,974 | -15,079 | -9,114 | 11,251 | 33,145 | Upgrade
|
| Book Value Per Share | 3092.30 | 2673.99 | 3052.82 | 2830.71 | 3292.31 | Upgrade
|
| Tangible Book Value | 10,590 | 9,370 | 26,671 | 52,114 | 60,061 | Upgrade
|
| Tangible Book Value Per Share | 528.07 | 499.75 | 1422.53 | 2779.59 | 3240.22 | Upgrade
|
| Land | 20,923 | 13,663 | 12,710 | 3,022 | 3,022 | Upgrade
|
| Buildings | 12,838 | 16,943 | 16,190 | 6,953 | 6,953 | Upgrade
|
| Machinery | 22,997 | 20,991 | 15,312 | 3,343 | 3,283 | Upgrade
|
| Construction In Progress | 5,345 | 2,886 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.